Frontiers in Genome Editing, published by FRONTIERS MEDIA SA, stands at the forefront of genomic research, specializing in the rapidly evolving realm of gene editing technologies. With an enthusiastic commitment to open access since 2020, this journal facilitates unrestricted distribution of cutting-edge research, making significant advancements in biotechnology and genetics accessible to a global audience. Located in Lausanne, Switzerland, Frontiers in Genome Editing publishes high-quality, peer-reviewed articles that contribute to the understanding and application of genome editing tools, such as CRISPR and TALEN, in various biological fields. Notably, as of 2023, the journal holds a prestigious Q1 ranking in Biotechnology and a Q2 ranking in Genetics, underscoring its importance and influence within these disciplines. With robust Scopus rankings, including a notable percentile placement, Frontiers in Genome Editing is an invaluable resource for researchers, professionals, and students dedicated to the promising future of genomic innovation.

Mitochondrial DNA Part A, published by Taylor & Francis Ltd, is a distinguished journal dedicated to the exploration of mitochondrial genetics and its implications for health and disease. With an ISSN of 2470-1394 and an E-ISSN of 2470-1408, this journal serves as an open-access platform, promoting the dissemination of high-quality research in the field. Operating from the United Kingdom, it offers a vital resource for researchers and professionals keen to delve into the rapidly evolving landscape of mitochondrial studies. Although currently ranked Q4 in both the Genetics and Molecular Biology categories, the journal continues to be a valuable outlet for emerging findings that could impact our understanding of cellular processes and hereditary conditions. Researchers can access articles and data covering recent advancements from 2016 through 2022, with ongoing contributions expected in 2024. As the field grows, so too does the importance of this journal as a source of knowledge and collaboration for the academic community.

Cold Spring Harbor Molecular Case Studies is a prestigious journal published by COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT, that has garnered considerable attention in the fields of Biochemistry, Genetics, and Molecular Medicine. With a focus on the intersection of molecular biology and clinical case studies, this journal serves as a key resource for researchers and practitioners seeking to explore novel insights into genetic disorders and biomedical advances. Its impact is underscored by its categorization in Q2 in various disciplines in 2023, reflecting its significance and influence within the academic community. Although currently not labeled as Open Access, Cold Spring Harbor Molecular Case Studies provides a rigorous platform for disseminating high-quality, peer-reviewed research that drives innovation and enhances understanding in these rapidly evolving fields. As a supporter of advancing scientific knowledge, this journal is essential for those dedicated to the exploration of molecular mechanisms and their clinical implications.

Frontiers in Genetics is a premier academic journal dedicated to advancing the field of genetics through high-quality, peer-reviewed research. Published by FRONTIERS MEDIA SA in Switzerland since 2010, this Open Access journal provides a platform for researchers and practitioners to disseminate innovative findings across various subfields, including clinical genetics and molecular medicine. With a notable emphasis on interdisciplinary approaches, the journal holds a strong position in the academic landscape, achieving Q2 rankings in key categories such as Genetics and Molecular Medicine in 2023. Not only does Frontiers in Genetics contribute to the scholarly dialogue by publishing impactful studies, but it also promotes accessibility to vital research, ensuring that knowledge is available to a global audience. This journal is a vital resource for researchers, professionals, and students looking to stay at the forefront of genetic discoveries and their applications, reflective of its engagement with contemporary challenges in genetics and healthcare.

Human Genome Variation, published by SpringerNature, is an esteemed open access journal dedicated to the field of genetic research and exploration. Since its inception in 2014, the journal has been at the forefront of advancing our understanding of human genome diversity and its implications in health and disease. With an E-ISSN of 2054-345X, it features a diverse array of studies that encompass biochemistry, genetics, and molecular biology, making it an invaluable resource for researchers and professionals alike. The journal holds a Q3 ranking in both biochemistry and genetics, and a Q4 ranking in molecular biology, highlighting its growing influence within these disciplines. As the landscape of genomics continues to evolve, Human Genome Variation serves as a platform for the dissemination of high-quality research, fostering collaboration and innovation within the scientific community. Researchers and academics are invited to contribute to this pivotal journal, which not only provides open access to its content since 2014 but also aims to bridge the gap between basic research and clinical applications in genetics.

Mitochondrial DNA Part B-Resources, published by TAYLOR & FRANCIS LTD, is a prominent academic journal focusing on the vast and evolving field of genetics and molecular biology. As an open access resource, it is dedicated to providing valuable insights and comprehensive data on mitochondrial DNA, an area crucial for understanding cellular functions, genetic inheritance, and various diseases. Although relatively new, having commenced in 2016, the journal has gained recognition with its current Scopus rankings placing it in the lower quartiles for both Genetics and Molecular Biology. It serves as an essential platform for researchers, professionals, and students at the intersection of genetics and biotechnology, fostering collaboration and innovation. With a commitment to quality research and accessibility, Mitochondrial DNA Part B-Resources is poised to contribute significantly to the scientific community until at least 2024 and beyond.

Genome Medicine is a prestigious, peer-reviewed journal published by BMC, focusing on the rapidly evolving fields of genetics, molecular biology, and molecular medicine. Established in 2009 and boasting an open-access format, it has become a leading platform for disseminating high-quality research findings that advance our understanding of genetic diseases and therapeutic innovations. With an impressive Q1 ranking across multiple relevant categories—in particular, genetics (clinical), molecular biology, and molecular medicine—this journal is recognized for its substantial impact in the academic community, as evidenced by its exceptional placement in Scopus rankings. By providing unrestricted access to groundbreaking studies, Genome Medicine fosters collaboration and knowledge sharing among researchers, clinicians, and educators, thus playing a vital role in the transition from fundamental genetic research to clinical applications. Researchers are encouraged to contribute their findings and insights, further solidifying the journal’s position as a pivotal resource for those dedicated to advancing genomic medicine.

Genes & Genomics is a prominent academic journal dedicated to the fields of biochemistry, genetics, and molecular biology, published by Springer from South Korea. With an evolving focus on innovative genetic research and its implications, this journal serves as a crucial platform for disseminating knowledge within the scientific community. The journal has been indexed in Scopus and boasts a Q3 quartile ranking in 2023 for its contributions to these disciplines, highlighting its relevance and growing impact. In addition to traditional subscription options, Genes & Genomics supports Open Access, offering broader accessibility for researchers and enthusiasts eager to explore the latest advancements in genetic studies. Since its inception in 2008, the journal has committed to publishing high-quality research that drives forward our understanding of genetics and its applications, making it an essential resource for researchers, professionals, and students alike who are passionate about the complexities and breakthroughs in genomic sciences.

MAMMALIAN GENOME is a leading journal in the field of genetics, aimed at advancing our understanding of the genetic makeup and evolutionary relationships of mammals. Published by Springer, this journal has been a cornerstone resource since its inception in 1991, converging extensive research up to 2024. With a commendable Q2 classification in the 2023 Genetics category and a Scopus Rank of #208 out of 347, it serves as a vital platform for sharing cutting-edge findings, methodologies, and reviews pertaining to mammalian genomes. Although not an open-access journal, MAMMALIAN GENOME ensures that its content is accessible through institutional subscriptions, catering to a global audience of researchers, professionals, and students. Its commitment to excellence in genetic research positions it as an essential publication for anyone striving to contribute to this dynamic field.

GENETICS AND MOLECULAR BIOLOGY, published by the SOC BRASIL GENETICA, is a prominent journal dedicated to the advancement of knowledge in the fields of genetics and molecular biology. Since its inception in 1998, this Open Access journal has served as a vital platform for researchers, professionals, and students to disseminate their findings and engage with the latest innovations and discoveries. With an impact factor that reflects its growing influence, GENETICS AND MOLECULAR BIOLOGY ranks in the Q3 category for both genetics and molecular biology as of 2023, indicating its position within the academic community. The journal is indexed in Scopus, highlighting its commitment to maintaining rigorous peer-review standards while providing wide-reaching access to quality research. Operating out of Ribeirão Preto, Brazil, it fosters a collaborative environment for academic discourse and research development not only in Brazil but also globally. The journal encourages submissions that explore a wide range of topics in genetics and molecular biology, making it an essential resource for anyone involved in these dynamic fields.